Lori L. Bostrom

584 total citations
10 papers, 332 citations indexed

About

Lori L. Bostrom is a scholar working on Organic Chemistry, Hematology and Molecular Biology. According to data from OpenAlex, Lori L. Bostrom has authored 10 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Organic Chemistry, 5 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in Lori L. Bostrom's work include Blood Coagulation and Thrombosis Mechanisms (5 papers), Synthesis and Catalytic Reactions (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). Lori L. Bostrom is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (5 papers), Synthesis and Catalytic Reactions (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). Lori L. Bostrom collaborates with scholars based in United States. Lori L. Bostrom's co-authors include James R. Pruitt, Robert M. Knabb, Ruth R. Wexler, Pancras C. Wong, Donald Pinto, Matthew Wright, Matthew M. Abelman, Mimi L. Quan, Stephen W. Wright and David J. Carini and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Lori L. Bostrom

10 papers receiving 308 citations

Peers

Lori L. Bostrom

OC

MB

HEMAT

CCM

IMMUN

Shuaige Wang United States

Hsingan Tsai United States

Joseph Cacciola United States

Pamela Nagafuji United States

Yasunori Hase Japan

Lan Trinh United States

Joscha Kotthaus Germany

Taisuke Hamamoto Japan

Sridhar Veeraraghavan India

Gino Beggiolin United States

Shuaige Wang United States

Lori L. Bostrom

171 ×1.1

OC

80 ×0.7

MB

103 ×1.2

HEMAT

60 ×1.1

CCM

9 ×0.2

IMMUN

Citations per year, relative to Lori L. Bostrom Lori L. Bostrom (= 1×) peers Shuaige Wang

Countries citing papers authored by Lori L. Bostrom

Since Specialization

Citations

This map shows the geographic impact of Lori L. Bostrom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori L. Bostrom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori L. Bostrom more than expected).

Fields of papers citing papers by Lori L. Bostrom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori L. Bostrom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori L. Bostrom. The network helps show where Lori L. Bostrom may publish in the future.

Co-authorship network of co-authors of Lori L. Bostrom

This figure shows the co-authorship network connecting the top 25 collaborators of Lori L. Bostrom. A scholar is included among the top collaborators of Lori L. Bostrom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori L. Bostrom. Lori L. Bostrom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Douty, Brent, Brian Wayland, J. Paul, et al.. (2007). Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines. Bioorganic & Medicinal Chemistry Letters. 18(1). 66–71. 55 indexed citations

2.

Pruitt, James R., Donald Pinto, Robert A. Galemmo, et al.. (2003). Discovery of 1-(2-Aminomethylphenyl)-3-trifluoromethyl-N- [3-fluoro-2‘-(aminosulfonyl)[1,1‘-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor. Journal of Medicinal Chemistry. 46(25). 5298–5315. 58 indexed citations

3.

Fevig, John M., Donald Pinto, Qi Han, et al.. (2001). Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core. Bioorganic & Medicinal Chemistry Letters. 11(5). 641–645. 31 indexed citations

4.

Pruitt, James R., Donald Pinto, Lori L. Bostrom, et al.. (2000). Isoxazolines and isoxazoles as factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(8). 685–689. 59 indexed citations

5.

Quan, Mimi L., Ann Y. Liauw, Christopher D. Ellis, et al.. (1999). Design and Synthesis of Isoxazoline Derivatives as Factor Xa Inhibitors. 1. Journal of Medicinal Chemistry. 42(15). 2752–2759. 64 indexed citations

6.

Galemmo, Robert A., John M. Fevig, David J. Carini, et al.. (1996). (N-acyl-N-alkyl)glycyl borolysine analogs: A new class of potent thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 6(24). 2913–2918. 11 indexed citations

7.

Wright, Stephen W., Joseph J. Petraitis, Matthew M. Abelman, et al.. (1994). Heteroaryl-Fused 2-Phenylisothiazolone Inhibitors of Cartilage Breakdown. Journal of Medicinal Chemistry. 37(19). 3071–3078. 16 indexed citations

8.

Wright, Stephen W., et al.. (1993). Inhibition of cartilage breakdown by isothiazolones. Bioorganic & Medicinal Chemistry Letters. 3(12). 2875–2878. 7 indexed citations

9.

Wright, Stephen W., et al.. (1992). Benzyl and t-butyl sulfoxides as sulfenyl halide equivalents: a convenient preparation of benzisothiazolones. Tetrahedron Letters. 33(2). 153–156. 22 indexed citations

10.

Blizzard, Timothy A., et al.. (1991). Conversion of avermectin B1 to 19-epi-avermectin B1. Tetrahedron Letters. 32(24). 2723–2726. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact